Unresectable Malignant Solid Neoplasm Terminated Phase 1 / 2 Trials for Pevonedistat (DB11759)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Terminated | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04800627 | Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor | Treatment |